Table 1.
Technical validation step | BGM ELISA |
---|---|
Target |
MMP-9 and -12 degradation of biglycan |
Lower limit of detection (LDL) |
1.54 ng/mL |
Dilution recovery of human serum |
100% (1:2), 103% (1:4) |
Dilution recovery of human plasma |
97% (1:2), 99% (1:4) |
Dilution recovery of rat serum |
107% (1:2), 102% (1:4) |
Dilution recovery of rat plasma |
89% (1:2) |
Dilution recovery of mouse serum |
105% (1:2) |
Dilution recovery of mouse plasma |
97% (1:2) |
Intra-assay variation |
10% |
Inter-assay variation | 15% |
Percentage dilution recovery and percentage intra/inter variation are indicated as mean values of different samples diluted 1:2 and 1:4 and as mean variation between ten individual determinations of human samples, respectively.